Skip to main content
Premium Trial:

Request an Annual Quote

BGI to Ramp up Sequencing Abilities with Illumina, Roche Tools

NEW YORK (GenomeWeb News) – The Beijing Genomics Institute is dramatically expanding its DNA sequencing capacity by adding fourteen new next-generation sequencers, BGI said today.

BGI said it has ordered 11 new Illumina Genome Analyzers and three Roche Genome Sequencer FLX instruments. The Institute already had six Illumina sequencers, as well as 26 3730xl sequencers from Applied Biosystems and 107 MegBACE-1000 sequencers from GE Healthcare.

The purchases are expected to bring BGI’s raw-sequencing data output to up to 16 Gbps per day or more, and the institute will “significantly increase [its] ability to market new generation sequencing services to the community.”

BGI recently announced plans to sequence the genome of the Giant Panda and a plan to work with the Sanger Institute and the National Institutes of Health to sequence the genetic codes of 1,000 people from around the world.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.